Company profile

Kohjin Bio Co., Ltd.

EDINET
E38689
Securities
177A
Industry
Pharmaceutical
Latest annual securities report
2026-06-23 Annual Securities Report PDF HTML
Latest financial report
—
Latest filing
2026-06-26 Extraordinary Report PDF HTML
Compare this company

Industry position

Pharmaceutical

View details
Profitability Average Current Top 50% 5-year trend Deteriorating
Financial strength Average Based on Equity ratio Current Top 48% 5-year trend Improving
Growth Weak Based on Revenue growth Current Bottom 17% 5-year trend Deteriorating
Cash generation Above average Current Top 43% 5-year trend Deteriorating

Latest half-year results

H1 FY2026

2025/04/01 - 2025/09/30

Consolidated · Japanese GAAP · Cumulative YTD

For H1 FY2026, revenue was ¥2.5 billion, down 0.1% year over year. Operating income was ¥257.65 million, down 32.2% year over year. Net income was ¥202.05 million, down 27.1% year over year.

Revenue ¥2.5B down 0.1% year over year
Operating income ¥257.65M down 32.2% year over year
Net income ¥202.05M down 27.1% year over year
Operating cash flow ¥201.73M
Free cash flow -¥316.4M
Total assets ¥8.84B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2026

Consolidated Japanese GAAP

Revenue reached ¥4.94 billion, down 5.1% year over year. Operating income was ¥341.54 million, down 65.5% year over year. Operating margin was 6.9%. Net income was ¥251.02 million, down 68.4% year over year. ROE was 4.2%; equity ratio was 66.8%; free cash flow was -¥169.16 million.

Revenue ¥4.94B down 5.1% year over year
Operating income ¥341.54M down 65.5% year over year
Net income ¥251.02M down 68.4% year over year
Total assets¥8.9B
Total equity—
Operating cash flow¥698.51M
Free cash flow-¥169.16M

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Average

Operating margin Top 50% / ROE Bottom 55%

Financial strength Average
Based on Equity ratio

Equity ratio Top 50%

Growth Weak
Based on Revenue growth

Revenue growth Bottom 86%

Cash generation Above average

Operating cash flow margin Top 31% / Free cash flow margin Bottom 60%

Profitability Industry position history Deteriorating
2026 Top 50% 2025 Top 15% 2024 Top 25%
Financial strength Industry position history Improving
2026 Top 48% 2025 Bottom 44% 2024 Bottom 27%
Growth Industry position history Deteriorating
2026 Bottom 17% 2025 Top 34%
Cash generation Industry position history Deteriorating
2026 Top 43% 2025 Top 37% 2024 Top 25%
Profitability Operating margin 6.9% Industry median 6.2% Top 50% Comparison sample 42
Profitability ROE 4.2% Industry median 4.4% Bottom 55% Comparison sample 48
Financial strength Equity ratio 66.8% Industry median 66.1% Top 50% Comparison sample 48
Growth Revenue growth -5.1% Industry median +5.1% Bottom 86% Comparison sample 42
Cash generation Operating cash flow margin 14.1% Industry median 6.2% Top 31% Comparison sample 42
Cash generation Free cash flow margin -3.4% Industry median -1.5% Bottom 60% Comparison sample 42

Annual financial data

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Share price Market cap Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2026 Consolidated Japanese GAAP 4939025000 341536000 340950000 251019000 251019000 286036000 8904397000 2959217000 5945179000 5800530000 5945179000 698508000 -867672000 -320756000 -169164000 2486185000 49.11 24.6 1208.106 6175354629.600 1163.08 5111600 0.6676677826 0.668 0.0422222779 0.0281904547 0.0691504902 0.0690318433 0.0508235937 0.1414262937 -0.0342504847 -0.0513344731 -0.6554092026 -0.679982955 -0.6841570841 -0.0178953677 0.0282537284 -0.2370627087 0.204628101 -1.2331021372 0.0352780154 -0.1570159636 -0.6883289966 0.0 0.0538922156 176
FY2025 Consolidated Japanese GAAP 5206287000 991135000 1065412000 794759000 794759000 843081000 9066648000 3284826000 5781821000 5672189000 5781821000 915551000 -1090901000 1376032000 -175350000 2949267000 157.57 11.1 1749.027 8940326413.200 1131.12 5111600 0.6377021585 0.638 0.1374582506 0.0876574231 0.1903727167 0.204639506 0.152653705 0.1758548847 -0.0336804329 0.0914428137 0.6606877763 0.6762276963 1.0644270582 0.3759606831 0.7298447549 0.111535898 -0.8894837483 1021.7952522255 -1.7118586269 0.7078033002 0.7047495402 0.22727491 0.0503144654 167
FY2024 Consolidated Japanese GAAP 4770096000 596822000 635601000 384978000 384978000 403698000 6589322000 3246928000 3342393000 3281083000 3342393000 823681000 -577354000 -1348000 246327000 1726936000 92.43 802.5 4165000 0.5072438409 0.507 0.1151803513 0.0584245238 0.1251173981 0.1332470038 0.0807065518 0.1726759797 0.0516398412 159

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp